Multi-site Adaptive Trials for COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

233

Participants

Timeline

Start Date

April 7, 2020

Primary Completion Date

September 7, 2020

Study Completion Date

September 7, 2020

Conditions
COVID-19
Interventions
DRUG

SOC + Intravenous Famotidine

Standard of Care treatment plus IV famotidine

DRUG

SOC + Placebo

Standard of Care treatment plus IV placebo

Trial Locations (5)

10075

Lenox Hill Hospital, New York

10549

Northern Westchester Hospital, Mount Kisco

11030

North Shore University Hospital, Manhasset

11040

Long Island Jewish Medical Center, Queens

11706

Southside Hospital, Bay Shore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Northwell Health

OTHER

NCT04370262 - Multi-site Adaptive Trials for COVID-19 | Biotech Hunter | Biotech Hunter